Chung, Amy W.

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Wheatley, A. K., Juno, J. A., Wang, J. J., Selva, K. J., Reynaldi, A., Tan, H.-X., Lee, W. S., Wragg, K. M., Kelly, H. G., Esterbauer, R., et al. (2021) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 351

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

Lee, W. S., Selva, K. J., Davis, S. K., Wines, B. D., Reynaldi, A., Esterbauer, R., Kelly, H. G., Haycroft, E. R., Tan, H.-X., Juno, J. A., et al. (2020) · Cell Reports Medicine

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 80

Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers

Fulford, T. S., Soliman, C., Castle, R. G., Rigau, M., Ruan, Z., Dolezal, O., Seneviratna, R., Brown, H. G., Hanssen, E., Hammet, A., et al. (2024) · Nature Immunology

T-cell and B-cell Immunologyvaccines and immunoinformatics approaches

Cited by 57